YSI 2940/2980 Multi-Channel Online Biochemical Analyzer

Overview

The YSI 2940/2980 Multi-Channel Online Biochemical Analyzer is an industrial-grade, real-time process monitoring system engineered for continuous, selective quantification of key biochemical analytes in dynamic bioprocess environments. Built upon YSI’s proprietary amperometric biosensor platform, the instrument employs enzyme-immobilized membrane electrodes—each sensor tailored to a specific substrate or metabolite via covalent or cross-linked enzyme fixation. This electrochemical detection architecture enables direct, label-free measurement of redox-active species generated during enzymatic catalysis (e.g., H₂O₂ from glucose oxidase or lactate oxidase reactions), yielding linear current responses proportional to analyte concentration. Unlike off-line HPLC or spectrophotometric methods, the 2940/2980 eliminates sampling delays, manual intervention, and analytical variability—supporting true in-situ, at-line, or online deployment directly integrated into bioreactor manifolds, perfusion loops, or fermentation skids. Its robust fluidic architecture—including low-shear microfluidic chambers, anti-fouling hydrophilic membranes, and self-cleaning flow paths—is validated for uninterrupted operation in high-turbidity, high-protein, and viscous media typical of mammalian cell culture (>10⁷ cells/mL) and microbial fermentations (e.g., E. coli, S. cerevisiae, CHO processes).

Key Features

• Multi-channel architecture supporting simultaneous, independent monitoring of up to 16 analytes across multiple bioreactors or process streams—enabling comparative kinetic profiling and parallel batch consistency assessment.
• Patented immobilized enzyme electrode technology delivering high specificity, minimal cross-reactivity, and long-term operational stability (typical sensor lifetime >30 days under continuous use).
• Sub-60-second response time per measurement cycle, with automated calibration verification and drift compensation algorithms embedded in firmware.
• Integrated peristaltic pumping and pressure-regulated flow control ensuring precise sample introduction without bubble formation or shear-induced cell lysis.
• Ruggedized stainless-steel and PEEK-wetted materials compliant with ASME BPE surface finish standards (Ra ≤ 0.4 µm) and compatible with SIP (Steam-in-Place) protocols up to 121°C.
• Modular sensor cartridge design allowing rapid field replacement without system shutdown or recalibration.

Sample Compatibility & Compliance

The YSI 2940/2980 is validated for direct interfacing with undiluted, unfiltered biological matrices—including fed-batch and perfusion cultures, anaerobic digesters, and continuous ethanol fermenters. Its cavity geometry and laminar flow dynamics mitigate particulate accumulation and biofilm adhesion, significantly reducing maintenance frequency relative to capillary-based analyzers. From a regulatory standpoint, the system supports audit-ready data integrity: all measurements are timestamped, sensor health metrics (baseline current, sensitivity slope, noise RMS) are logged continuously, and user actions are tracked in accordance with FDA 21 CFR Part 11 requirements when paired with compliant LIMS or SCADA systems. It aligns with ICH Q5, Q8, and Q9 frameworks for Quality by Design (QbD) and Process Analytical Technology (PAT) implementation, and meets relevant sections of ISO 13485 for in-process instrumentation used in medical device manufacturing.

Software & Data Management

The analyzer operates under YSI BioView™ v4.x software—a Windows-based platform offering real-time trend visualization, multi-parameter overlay, alarm threshold configuration (high/low, rate-of-change), and automated report generation (PDF/CSV). Raw sensor output undergoes on-board digital filtering (Butterworth low-pass), temperature-compensated signal linearization, and outlier rejection using iterative Grubbs’ test. Data export supports OPC UA and Modbus TCP protocols for seamless integration into DeltaV, Emerson DCS, or Siemens PCS7 environments. Audit trails include operator ID, calibration event logs, sensor swap records, and firmware version history—all retained for ≥12 months and exportable for regulatory submission.

Applications

• Biopharmaceutical process development and manufacturing: Real-time tracking of glucose depletion, lactate accumulation, and amino acid consumption during monoclonal antibody production in CHO bioreactors.
• Industrial biotechnology: Monitoring glycerol uptake and 1,3-propanediol formation in Klebsiella pneumoniae fermentations for bio-based chemical synthesis.
• Clinical research laboratories: Quantitative analysis of whole-blood lactate in ex vivo perfusion models or organ-on-chip systems—without hemolysis-induced artifacts.
• Food & beverage quality assurance: In-line monitoring of sugar-to-acid ratios during yogurt fermentation or ethanol buildup in wine must.
• Academic bioprocess labs: High-resolution metabolic flux analysis across replicate bioreactor arrays under varying pH, DO, or feed strategies.

FAQ

What analytes can the YSI 2940/2980 measure simultaneously?
The system supports configurable sensor modules for up to 16 distinct analytes—including glucose, lactate, glutamate, glutamine, acetate, ethanol, methanol, glycerol, and pyruvate—depending on installed electrode cartridges and firmware licensing.
Is the analyzer suitable for sterile, closed-system bioprocessing?
Yes. The 2940/2980 is designed for integration into aseptic workflows; its fluid path components meet USP Class VI biocompatibility, and optional steam-sterilizable sensor housings are available for SIP-compliant installations.
How often do sensors require calibration or replacement?
Factory-calibrated sensors typically maintain accuracy for 2–4 weeks under continuous operation; calibration verification is recommended every 24 hours using certified standard solutions, and full recalibration every 72 hours in GMP environments.
Can the system interface with existing MES or SCADA platforms?
Yes—via native OPC UA, Modbus TCP, or analog 4–20 mA outputs. YSI provides detailed protocol documentation and engineering support for system-level integration validation.
Does the analyzer comply with FDA 21 CFR Part 11 for electronic records?
When deployed with YSI BioView™ configured in “21 CFR Part 11 Mode” (requiring role-based login, electronic signatures, and immutable audit trail storage), the system satisfies predicate rule requirements for electronic records and signatures in regulated biomanufacturing.